3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Li, G; Liang, S; Liu, S; Lv, Q; Wang, S; Wen, S; Wu, B; Xie, J; Xie, Q; Xie, W; Xu, C; Xu, H; Xue, Y; Zhang, C; Zhang, X; Zou, L | 1 |
| Adinolfi, E; Baricordi, OR; Chiozzi, P; Di Virgilio, F; Morelli, A; Rizzo, R; Solini, A | 1 |
2 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia.
Topics: Adenosine Triphosphate; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fluorescent Antibody Technique; Ganglia, Spinal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; HEK293 Cells; Humans; Hyperalgesia; Ion Channel Gating; Neural Conduction; Neuralgia; Protein Binding; Receptors, Purinergic P2X7; RNA, Long Noncoding; RNA, Messenger; RNA, Small Interfering; Sensory Receptor Cells; Tumor Necrosis Factor-alpha | 2016 |
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Diphosphate; Adenosine Triphosphate; Apoptosis; Apyrase; Autocrine Communication; Cell Shape; Cytidine Triphosphate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fibroblasts; Fibronectins; Gene Expression Regulation; Humans; Interleukin-6; Membrane Potentials; Paracrine Communication; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Uridine Diphosphate; Uridine Triphosphate | 2004 |